Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This quick intro compares Roth and Traditional accounts to see which grows faster over a short period. Learn the key factors that influence growth and what to consider before choosing.
24,745 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A bold contrarian wager on semiconductors has underperformed as AI demand sustains a rally. Leveraged, daily-reset fu...
Goldman Sachs has quietly built a $154 million stake in spot XRP ETFs, making it the largest disclosed holder as XRP ...
Sunway Healthcare opened sharply higher on its first trading day after a multi-billion ringgit IPO, reflecting growin...
The 2025 ATTOM report shows a sharp slowdown in home flipping activity, with profits slipping to pre-crisis levels as...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
A sharp one-week drop surprised many investors. This analysis explains the drivers behind the decline, from KPI discl...
BTS returns with a high-profile comeback tour after completing military service, signaling a push to reclaim global p...
The FMC stock story has been rough, but a measured, scenario-driven approach can illuminate where the year ahead migh...
Spring 2026 opens with renewed urgency as loan costs rise and builders push incentives. The market watches mortgage r...
The Philippines moved to shield households from rising energy costs after the Middle East conflict intensified, decla...
March PMI data show slowing U.S. growth with rising costs. Bitcoin reacts nervously, facing renewed macro risk as tra...